-
, we focus on human observational and intervention studies as well as cell- based model studies and apply advanced data-driven approaches and state of the art biochemical and OMICs technologies
-
and apply advanced data-driven approaches and state of the art biochemical and OMICs technologies to understand and predict the role of foods, dietary components and dietary patterns in human health
-
of Chemical Biology (ChemBio), we combine and develop protein engineering, synthetic chemistry, nucleic acid technology, and state-of-the-art biophysical methods (spectroscopy, live cell imaging and
-
chemistry, nucleic acid technology, and state-of-the-art biophysical methods (spectroscopy, live cell imaging and nanotechnology) to address cutting-edge questions in biology and meet medical challenges. Our
-
barcoding to study individual tumor subclones, state-of-the-art organoid technologies, high-throughput drug screening and single-cell sequencing. The position will be co-supervised by Professor Jens Lagergren
-
therapies for children with cancer. We do this by applying several different methods and techniques, including cell barcoding to study individual tumor subclones, state-of-the-art organoid technologies, high
-
starting 2025-01-02 or by agreement. Application deadline is 2024-03-15. The appointment is supported by the TAIGA Focus Areas in: Art & AI led by UmArts, and CELS Critical, Ethical, Legal and Social aspects
-
. Support for innovative research and access to state-of-the-art facilities. Is this interesting for you? Welcome with your application at latest February 29, 2024. Project description and working tasks
-
wide international network across faculties and disciplines. Opportunities to engage with policymakers and influence AI policy development. Support for innovative research and access to state-of-the-art